Prevention: Direct FY2010 Prevention of Mother-to-Child Transmission Program Results


Countries

Number of pregnant women with known HIV status(includes women who were tested for HIV and received their results)1

Number of HIV+ pregnant women receiving ARV prophylaxis

Estimated infant HIV infections averted2

Angola

72,000

900

171

Botswana3

0

0

0

Cambodia

99,800

300

57

China

64,700

100

19

Côte d’Ivoire

345,700

11,000

2,090

Democratic Republic of the Congo

126,700

1,300

247

Dominican Republic

38,300

200

38

Ethiopia

590,000

10,500

1,995

Ghana3,4

0

NA

NA

Guyana

9,700

100

19

Haiti

131,800

1,100

209

India

194,100

700

133

Indonesia4

NA

NA

NA

Kenya

1,177,400

70,400

13,376

Lesotho

28,100

5,600

1,064

Malawi

184,000

20,900

3,971

Mozambique

520,600

40,200

7,638

Namibia

54,700

5,600

1,064

Nigeria

673,800

28,200

5,358

Russia4

22

NA

NA

Rwanda

131,800

4,200

798

South Africa

682,400

207,100

39,349

Sudan

9,000

300

57

Swaziland

20,700

7,600

1,444

Tanzania

1,374,700

58,800

11,172

Thailand4

NA

NA

NA

Uganda

758,600

33,100

6,289

Ukraine4

NA

NA

NA

Vietnam

403,500

1,200

228

Zambia

477,300

66,400

12,616

Zimbabwe

215,600

26,700

5,073

Regions

     

Caribbean Regional4

NA

NA

NA

Central America4

NA

NA

NA

Central Asia4

NA

NA

NA

Total

8,385,022

602,500

114,475

Notes:
Numbers may be adjusted as attribution criteria and reporting systems are refined.
All numbers greater than 100 have been rounded off to the nearest 100.

Footnotes:

1 This is a revised indicator for FY2010. This indicator has two components: 1) the number of women with known positive HIV infection attending an ANC for a new pregnancy over the last reporting period; and 2) the number of women attending ANC, Labor and Delivery sites who were tested for HIV and received results (which is also captured under the testing and counseling results). The previous PMTCT indicator: “the number of pregnant women receiving PMTCT services” included only women who were counseled and tested and received their test results. For further information, refer to Indicator P1.1.D in the PEPFAR Next Generation Indicator Guidance on http://www.pepfar.gov/guidance/index.htm.

2 The estimated number of infant HIV infections averted is calculated by multiplying the total number of HIV+ pregnant women receiving ARV prophylaxis by 19 percent, to represent regimen effectiveness. This is an approximation of infections averted using a single-dose nevirapine regimen, which is expected to reduce HIV transmission from about 35% to approximately 16 percent. However, this is likely a significant underestimate. Many countries are beginning to use more effective drug regimens for some of their PMTCT participants as per 2006 and 2010 WHO guidelines but countries do not yet report regimen-specific data. As a result the 19 percent estimation methodology is used to be conservative. Starting in FY 2011 PEPFAR PMTCT country programs will be reporting PMTCT ARV uptake by regimen (ART for treatment, AZT + NVP, triple drug prophylaxis), allowing us to develop better estimates for infant infections averted based on the specific regimens received by the woman.

3 “0” refers to countries that did not directly support PMTCT programs.

4 “NA” refers to countries or regions where USG did not support PMTCT or PMTCT ARV prophylaxis programs.

Back to Top

USA.gov U.S. Government interagency website managed by the Office of U.S. Global AIDS Coordinator
and the Bureau of Public Affairs, U.S. State Department.
External Link Policy | Copyright Information | Privacy | FOIA